DexCom, Inc. (DXCM)
NASDAQ · Healthcare
DexCom, Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 4.66B | 4.03B | 3.62B | 2.91B | 2.45B | 1.93B | 1.48B | 1.03B | 718.5M | 573.3M | 402.0M | 259.2M | 160.0M | 99.9M | 76.3M | 48.6M | 29.7M |
| Gross Profit | 2.80B | 2.44B | 2.29B | 1.88B | 1.68B | 1.28B | 931.5M | 663.9M | 492.1M | 378.4M | 278.4M | 176.3M | 100.1M | 46.6M | 35.9M | 18.4M | 3.7M |
| Profitability | |||||||||||||||||
| Operating Income | 911.8M | 600.0M | 597.7M | 391.2M | 265.8M | 299.5M | 142.3M | -186.3M | -42.5M | -63.9M | -57.1M | -21.5M | -28.9M | -55.7M | -44.8M | -45.3M | -45.8M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | 836.3M | 576.2M | 541.5M | 341.2M | 216.9M | 549.7M | 101.1M | -127.1M | -50.2M | -65.6M | -57.6M | -22.4M | -29.8M | -54.5M | -44.7M | -55.2M | -53.5M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 406M | 413M | 426M | 428M | 429M | 420M | 92M | 88M | 86M | 85M | 82M | 77M | 73M | 70M | 68M | 62M | — |
DexCom, Inc. Income Statement — FAQ
DexCom, Inc. (DXCM) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see DXCM's income statement history?
The chart and table above show DexCom, Inc.'s income statement by year and by quarter, including the growth rate.